SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001387131-19-008666
Filing Date
2019-11-14
Accepted
2019-11-14 09:25:05
Documents
12

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM S-1 tnxp-s1a_111319.htm S-1/A 591166
2 FORM OF UNDERWRITING AGREEMENT ex1-01.htm EX-1.01 294987
3 FORM OF WARRANT AGREEMENT, ex4-02.htm EX-4.02 112076
4 FORM OF SECOND COMMON WARRANT ex4-03.htm EX-4.03 140299
5 FORM OF WARRANT AGENCY AGREEMENT ex4-04.htm EX-4.04 86653
6 FORM OF WARRANT AGREEMENT ex4-05.htm EX-4.05 225301
7 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 18113
8 OPINION OF LOWENSTEIN SANDLER, LLP ex5-02.htm EX-5.02 12262
9 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-01.htm EX-23.01 4454
10 GRAPHIC tnxp001.jpg GRAPHIC 6827
11 GRAPHIC tnxp002.jpg GRAPHIC 13059
12 GRAPHIC ex5-01_img001.jpg GRAPHIC 16253
  Complete submission text file 0001387131-19-008666.txt   1531156
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-234263 | Film No.: 191216855
SIC: 2834 Pharmaceutical Preparations